FOXO TECHNOLOGIES INC. Stock-Based Compensation
FOXO TECHNOLOGIES INC. (FOXO) reported Stock-Based Compensation of -$9.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was -$9.10M, a 48304.26% decline year-over-year.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.00.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was -$210.80K.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $18.88K, a 72.56% decline year-over-year.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2025 was -$164.21K.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2024 was -$101.73K, a 126.68% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2023 was $381.38K.
- FOXO TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2021 was $131.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.10M 10-Q · filed 2026-08-14 | -$9.13M 10-Q · filed 2026-08-14 | ||||||
| 2025-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$210.80K derived: sum of 2 quarters · filed 2026-04-15 | -$191.93K derived: sum of 3 quarters · filed 2026-08-14 | -$164.21K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$210.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$191.93K derived: sum of 2 quarters · filed 2026-08-14 | -$164.21K 10-Q · filed 2025-11-10 | -$358.77K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $18.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $46.59K 10-Q · filed 2026-08-14 | -$147.97K derived: sum of 3 quarters · filed 2026-08-14 | -$242.16K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $27.72K 10-Q · filed 2026-05-15 | -$166.85K derived: sum of 2 quarters · filed 2026-05-15 | -$261.04K derived: sum of 3 quarters · filed 2026-05-15 | -$192.24K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$194.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$288.75K derived: sum of 2 quarters · filed 2026-04-15 | -$219.96K derived: sum of 3 quarters · filed 2026-04-15 | -$101.73K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$94.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$25.39K derived: sum of 2 quarters · filed 2025-11-10 | $92.83K 10-Q · filed 2025-11-10 | $94.00K 10-Q · filed 2024-11-19 | $113.21K derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $68.80K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $187.02K 10-Q · filed 2025-08-19 | $187.00K 10-Q · filed 2024-08-19 | $207.40K derived: sum of 3 quarters · filed 2025-08-19 | -$1.10M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | $118.22K 10-Q/A · filed 2025-08-19 | $119.00K 10-Q · filed 2024-06-28 | $138.60K derived: sum of 2 quarters · filed 2025-08-19 | -$1.17M derived: sum of 3 quarters · filed 2025-08-19 | -$401.40K derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $20.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$1.29M derived: sum of 2 quarters · filed 2025-04-15 | -$519.62K derived: sum of 3 quarters · filed 2025-04-15 | $381.38K 10-K · filed 2025-04-15 | $381.00K 10-K · filed 2024-06-06 | |||
| 2023-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$540.00K derived: sum of 2 quarters · filed 2024-11-19 | $361.00K 10-Q · filed 2024-11-19 | $8.46M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2023-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $1.67M 10-Q · filed 2024-08-19 | $9.77M derived: sum of 3 quarters · filed 2026-08-14 | $10.31M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2023-03-31 | $901.00K 10-Q · filed 2024-06-28 | $9.00M derived: sum of 2 quarters · filed 2026-08-14 | $9.54M derived: sum of 3 quarters · filed 2026-08-14 | $9.77M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2022-12-31 | $8.10M derived: 10-Q 12 month − 10-Q/A 9 month · filed 2026-08-14 | $8.64M derived: sum of 2 quarters · filed 2026-08-14 | $8.87M derived: sum of 3 quarters · filed 2026-08-14 | $9.10M 10-Q · filed 2026-08-14 | $11.04M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $541.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $771.00K derived: sum of 2 quarters · filed 2024-06-04 | $1.00M 10-Q/A · filed 2024-06-04 | $1.13M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2022-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $461.00K 10-Q · filed 2023-08-10 | $584.00K derived: sum of 3 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | $231.00K 10-Q · filed 2023-05-11 | $354.00K derived: sum of 2 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $131.00K 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | $8.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |